PRESS RELEASE published on 10/14/2025 at 22:00, 5 months 12 days ago Inventiva Announces the Implementation of a New ATM Program Inventiva implements new ATM program, files Registration Statement with the SEC for up to $100 million aggregate gross sales proceeds. Proceeds to fund research and development, working capital, and corporate purposes Biopharmaceutical SEC Registration Statement Inventiva ATM Program
BRIEF published on 10/07/2025 at 22:05, 5 months 19 days ago Inventiva at Liver Meeting 2025: Key Presentations on Lanifibranor Digital Pathology Inventiva MASH Lanifibranor Liver Meeting 2025
PRESS RELEASE published on 10/07/2025 at 22:00, 5 months 19 days ago Inventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025 Inventiva to present multiple abstracts at AASLD The Liver Meeting® 2025 showcasing digital pathology data and therapeutic benefits of lanifibranor in MASH treatment. Visit booth #745 for more Digital Pathology Inventiva MASH Lanifibranor AASLD The Liver Meeting
BRIEF published on 10/01/2025 at 08:35, 5 months 26 days ago Andrew Obenshain Appointed as CEO of Inventiva Leadership Transition Drug Development Inventiva MASH Treatment Andrew Obenshain
PRESS RELEASE published on 10/01/2025 at 08:30, 5 months 26 days ago Inventiva Appoints Andrew Obenshain as Chief Executive Officer Inventiva appoints Andrew Obenshain as Chief Executive Officer, succeeding Frédéric Cren, to lead company's growth and prepare for potential commercialization in the United States Chief Executive Officer Inventiva MASH Frédéric Cren Andrew Obenshain
BRIEF published on 09/24/2025 at 22:05, 6 months 2 days ago Inventiva organizes an event for analysts and investors Event Phase 3 Inventiva MASH Lanifibranor
PRESS RELEASE published on 09/24/2025 at 22:00, 6 months 2 days ago Inventiva to Host Analyst and Investor Event on October 8, 2025 Inventiva to host analyst and investor event on October 8, 2025 featuring updates on lanifibranor and key MASH trends. Renowned experts to share insights on MASH landscape Inventiva Lanifibranor Analyst Event MASH Trends Expert Insights
BRIEF published on 08/25/2025 at 10:02, 7 months 1 day ago JP Morgan crosses threshold at Inventiva Voting Rights Actions Threshold Crossing JP Morgan Inventiva
BRIEF published on 08/25/2025 at 10:01, 7 months 1 day ago Threshold crossing for Inventiva Actions AMF Threshold Crossing Inventiva Great Point Partners
BRIEF published on 08/19/2025 at 15:40, 7 months 7 days ago JP Morgan crosses threshold in INVENTIVA Actions Financial Market JP Morgan Crossing InVentura
Published on 03/27/2026 at 08:05, 57 minutes ago Battery X Metals Announces Corporate Awareness Engagements
Published on 03/26/2026 at 23:00, 10 hours 2 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 10 hours 57 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 11 hours 2 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 11 hours 2 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/27/2026 at 07:45, 1 hour 17 minutes ago Pyrum Innovations AG publishes preliminary results for financial year 2025
Published on 03/27/2026 at 07:30, 1 hour 32 minutes ago DKSH Performance Materials Acquires AIC Ingredients, a Leading Customized Food Solutions Manufacturer in Malaysia
Published on 03/27/2026 at 07:30, 1 hour 32 minutes ago Haier Celebrates Excellence in Paris With New Smart Home Portfolio
Published on 03/27/2026 at 07:00, 2 hours 2 minutes ago Edisun Power Europe AG: Demanding year reinforces the urgency of advancing the ‘Renewables to AI’ strategy
Published on 03/26/2026 at 18:17, 14 hours 45 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 17:45, 15 hours 17 minutes ago Cegedim: profitability continues to improve
Published on 03/26/2026 at 07:30, 1 day 1 hour ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
